Edmund Lee

Edmund Lee

Company: Regulus Therapeutics

Job title: Executive Director, Biology


Results From the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) 12:30 pm

• Translational research leading up to the development of clinically relevant urinary biomarkers for ADPKD • Preclinical data supporting the use of the newly-developed biomarkers in RGLS4326 clinical trials • Clinical data demonstrating target engagement and proof of mechanism in early phase of clinical developmentRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.